MicroRNAs affecting the susceptibility of melanoma cells to CD8+ T cell-mediated cytolysis

被引:5
作者
Pane, Antonino A. A. [1 ,2 ,8 ,9 ]
Kordass, Theresa [1 ,2 ]
Hotz-Wagenblatt, Agnes [3 ]
Dickes, Elke [1 ]
Kopp-Schneider, Annette [4 ]
Will, Rainer [5 ]
Seliger, Barbara [6 ]
Osen, Wolfram [1 ]
Eichmueller, Stefan B. B. [1 ,7 ]
机构
[1] German Canc Res Ctr, Res Grp GMP & T Cell Therapy, Heidelberg, Germany
[2] Heidelberg Univ, Fac Biosci, Heidelberg, Germany
[3] German Canc Res Ctr, Om IT & Data Management Core Facil, Heidelberg, Germany
[4] German Canc Res Ctr, Dept Biostat, Heidelberg, Germany
[5] German Canc Res Ctr, Core Facil Cellular Tools, Heidelberg, Germany
[6] Martin Luther Univ Halle Wittenberg, Inst Med Immunol, Halle, Germany
[7] German Canc Res Ctr, Res Grp GMP& T Cell Therapy, Heidelberg, Germany
[8] Immatics Biotechnol GmbH, Tubingen, Germany
[9] Univ Clin Heidelberg, Sect Multiple Myeloma Internal Med 5, Heidelberg, Germany
关键词
cytotoxic T lymphocyte (CTL); melanoma; miRNA; Ndufa1; Psmc3; screening; DOWN-REGULATION; CANCER-CELLS; RESISTANCE; PROGRESSION; PROTEASOME; PHENOTYPE; BLOCKADE; THERAPY; PATHWAY; GENES;
D O I
10.1002/ctm2.1186
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe regulatory functions of microRNAs (miRNAs) in anti-tumour immunity have been mainly described in immune effector cells. Since little is known about miRNA effects on the susceptibility of target cells during T cell-target cell interaction, this study focused on the identification of miRNAs expressed in tumour cells controlling their susceptibility to CD8(+) T cell-mediated cytotoxicity. MethodsLuciferase expressing B16F10 melanoma (B16F10 Luci(+)) cells transfected with individual miRNAs covering a comprehensive murine miRNA library were screened for their susceptibility to lysis by an established cytotoxic T lymphocyte (CTL) line (5a, clone N beta) specific for the melanoma-associated antigen tyrosinase-related protein 2. miRNAs with the most pronounced effects on T cell-mediated lysis were validated and stably expressed in B16F10 cells. In silico analyses identified common targets of miRNA sets determined by the screen, which were further confirmed by small interfering RNA (siRNA)-mediated silencing experiments modulating immune surveillance. The Ingenuity Pathway Analysis (IPA) software and RNA sequencing (RNA-seq) data from miRNA-overexpressing cell lines were applied to investigate the underlying mechanisms. The Cancer Genome Atlas (TCGA)-derived miRNA sequencing data were used to assess the correlation of miRNA expression with melanoma patients' survival. ResultsThe miRNA screen resulted in the selection of seven miRNAs enhancing CTL-mediated melanoma cell killing in vitro. Upon stable overexpression of selected miRNAs, hsa-miR-320a-3p, mmu-miR-7037-5p and mmu-miR-666-3p were determined as most effective in enhancing susceptibility to CTL lysis. In silico analyses and subsequent siRNA-mediated silencing experiments identified Psmc3 and Ndufa1 as common miRNA targets possibly involved in the functional effects observed. The analyses of RNA-seq data with IPA showed pathways, networks, biological functions and key molecules potentially involved in the miRNA-mediated functional effects. Finally, based on TCGA data analysis, a positive correlation of the conserved miRNAs among the panel of the seven identified miRNAs with overall survival of melanoma patients was determined. ConclusionsFor the first time, this study uncovered miRNA species that affect the susceptibility of melanoma cells to T cell-mediated killing. These miRNAs might represent attractive candidates for novel therapy approaches against melanoma and other tumour entities.
引用
收藏
页数:20
相关论文
共 50 条
[41]   Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity [J].
Onda, Masanori ;
Kobayashi, Kazuto ;
Pastan, Ira .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (10) :4575-4582
[42]   Synergistic Enhancement of CD8+ T Cell-Mediated Tumor Vaccine Efficacy by an Anti-Transforming Growth Factor-β Monoclonal Antibody [J].
Terabe, Masaki ;
Ambrosino, Elena ;
Takaku, Shun ;
O'Konek, Jessica J. ;
Venzon, David ;
Lonnin, Scott ;
McPherson, John M. ;
Berzofsky, Jay A. .
CLINICAL CANCER RESEARCH, 2009, 15 (21) :6560-6569
[43]   Endometrial Cancer Suppresses CD8+T Cell-Mediated Cytotoxicity in Postmenopausal Women [J].
Patel, Mickey V. ;
Shen, Zheng ;
Rodriguez-Garcia, Marta ;
Usherwood, Edward J. ;
Tafe, Laura J. ;
Wira, Charles R. .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[44]   9-Gene Signature Correlated With CD8+ T Cell Infiltration Activated by IFN-γ: A Biomarker of Immune Checkpoint Therapy Response in Melanoma [J].
Yan, Kexin ;
Lu, Yuxiu ;
Yan, Zhangyong ;
Wang, Yutao .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[45]   A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing [J].
Pan, Deng ;
Kobayashi, Aya ;
Jiang, Peng ;
de Andrade, Lucas Ferrari ;
Tay, Rong En ;
Luoma, Adrienne M. ;
Tsoucas, Daphne ;
Qiu, Xintao ;
Lim, Klothilda ;
Rao, Prakash ;
Long, Henry W. ;
Yuan, Guo-Cheng ;
Doench, John ;
Brown, Myles ;
Liu, X. Shirley ;
Wucherpfennig, Kai W. .
SCIENCE, 2018, 359 (6377) :770-+
[46]   CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma [J].
van Hooren, Luuk ;
Handgraaf, Shanna M. ;
Kloosterman, Daan J. ;
Karimi, Elham ;
van Mil, Lotte W. H. G. ;
Gassama, Awa A. ;
Solsona, Beatriz Gomez ;
de Groot, Marnix H. P. ;
Brandsma, Dieta ;
Quail, Daniela F. ;
Walsh, Logan A. ;
Borst, Gerben R. ;
Akkari, Leila .
NATURE CANCER, 2023, 4 (05) :665-+
[47]   Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function [J].
Veatch, Joshua R. ;
Lee, Sylvia M. ;
Shasha, Carolyn ;
Singhi, Naina ;
Szeto, Julia L. ;
Moshiri, Ata S. ;
Kim, Teresa S. ;
Smythe, Kimberly ;
Kong, Paul ;
Fitzgibbon, Matthew ;
Jesernig, Brenda ;
Bhatia, Shailender ;
Tykodi, Scott S. ;
Hall, Evan T. ;
Byrd, David R. ;
Thompson, John A. ;
Pillarisetty, Venu G. ;
Duhen, Thomas ;
Houghton, A. McGarry ;
Newell, Evan ;
Gottardo, Raphael ;
Riddell, Stanley R. .
CANCER CELL, 2022, 40 (04) :393-+
[48]   Interleukin-33 pretreatment promotes metastatic growth of murine melanoma by reducing the cytotoxic capacity of CD8+ T cells and enhancing regulatory T cells [J].
Jevtovic, Andra ;
Pantic, Jelena ;
Jovanovic, Ivan ;
Milovanovic, Marija ;
Stanojevic, Ivan ;
Vojvodic, Danilo ;
Arsenijevic, Nebojsa ;
Lukic, Miodrag L. ;
Radosavljevic, Gordana D. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (08) :1461-1475
[49]   Increased Infiltration of CD8+ T Cells by Dacarbazine in a Patient with Mucosal Penile Melanoma Refractory to Nivolumab [J].
Funazumi, Masato ;
Namiki, Takeshi ;
Arima, Yumi ;
Kato, Kohei ;
Nojima, Kohei ;
Tanaka, Kentaro ;
Miura, Keiko ;
Yokozeki, Hiroo .
ANNALS OF DERMATOLOGY, 2016, 28 (04) :486-490
[50]   Enhanced chemo-immunotherapy against melanoma by inhibition of cholesterol esterification in CD8+ T cells [J].
Li, Man ;
Yang, Yuting ;
Wei, Jiaojie ;
Cun, Xingli ;
Lu, Zhengze ;
Qiu, Yue ;
Zhang, Zhirong ;
He, Qin .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2018, 14 (08) :2541-2550